• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Human Papillomavirus (HPV) Testing Market Size, Status and Forecast 2020-2026

report cover
  • 31 July 2020
  • Pharmaceuticals
  • 127 Pages
  • Report Code: 24LS-16421
  • Formate :   
Download FREE Report Sample Download PDF File

Human Papillomavirus Testing -MARKET ADVISORY SERVICES

Human Papillomavirus (HPV) Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Papillomavirus (HPV) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Roche
Agilent Technologies
Becton, DickinsonandCompany
QiagenN.V.
Thermo FisherScientificInc.
Abbott Laboratories
HologicInc.
CepheidInc.
SeegeneInc.
TakaraBio Inc.
DaAnGeneof SunYat-SenUniversity
PromegaCorporation
GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
Enzo Biochem Inc.
NorgenBiotek
DiagCorBioscienceIncLtd
Hybribio Limited
ZytovisionGmbH
ArborVitaCorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics

Market segment by Type, the product can be split into
Pap Smear Test
HPV DNA Test
Market segment by Application, split into
Diagnostic Centers
Hospitals
Clinic

Market segment by Regions/Countries, this report covers
NortHAmerica
Europe
China
Japan
Southeast Asia
India
Central& SoutHAmerica
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Papillomavirus (HPV) Testing Revenue
1.4 Market by Type
1.4.1 Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pap Smear Test
1.4.3 HPV DNA Test
1.5 Market by Application
1.5.1 Global Human Papillomavirus (HPV) Testing Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Centers
1.5.3 Hospitals
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Human Papillomavirus (HPV) Testing Market Perspective (2015-2026)
2.2 Global Human Papillomavirus (HPV) Testing Growth Trends by Regions
2.2.1 Human Papillomavirus (HPV) Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Papillomavirus (HPV) Testing Historic Market Share by Regions (2015-2020)
2.2.3 Human Papillomavirus (HPV) Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Human Papillomavirus (HPV) Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Human Papillomavirus (HPV) Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Human Papillomavirus (HPV) Testing Players by Market Size
3.1.1 Global Top Human Papillomavirus (HPV) Testing Players by Revenue (2015-2020)
3.1.2 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Papillomavirus (HPV) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio
3.2.1 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Papillomavirus (HPV) Testing Revenue in 2019
3.3 Human Papillomavirus (HPV) Testing Key Players Head office and Area Served
3.4 Key Players Human Papillomavirus (HPV) Testing Product Solution and Service
3.5 Date of Enter into Human Papillomavirus (HPV) Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Human Papillomavirus (HPV) Testing Historic Market Size by Type (2015-2020)
4.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020)
5.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Application (2021-2026)

6 NortHAmerica
6.1 NortHAmerica Human Papillomavirus (HPV) Testing Market Size (2015-2020)
6.2 Human Papillomavirus (HPV) Testing Key Players in NortHAmerica (2019-2020)
6.3 NortHAmerica Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020)
6.4 NortHAmerica Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Human Papillomavirus (HPV) Testing Market Size (2015-2020)
7.2 Human Papillomavirus (HPV) Testing Key Players in Europe (2019-2020)
7.3 Europe Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020)
7.4 Europe Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020)

8 China
8.1 China Human Papillomavirus (HPV) Testing Market Size (2015-2020)
8.2 Human Papillomavirus (HPV) Testing Key Players in China (2019-2020)
8.3 China Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020)
8.4 China Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Human Papillomavirus (HPV) Testing Market Size (2015-2020)
9.2 Human Papillomavirus (HPV) Testing Key Players in Japan (2019-2020)
9.3 Japan Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020)
9.4 Japan Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Human Papillomavirus (HPV) Testing Market Size (2015-2020)
10.2 Human Papillomavirus (HPV) Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020)

11 India
11.1 India Human Papillomavirus (HPV) Testing Market Size (2015-2020)
11.2 Human Papillomavirus (HPV) Testing Key Players in India (2019-2020)
11.3 India Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020)
11.4 India Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020)

12 Central& SoutHAmerica
12.1 Central& SoutHAmerica Human Papillomavirus (HPV) Testing Market Size (2015-2020)
12.2 Human Papillomavirus (HPV) Testing Key Players in Central& SoutHAmerica (2019-2020)
12.3 Central& SoutHAmerica Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020)
12.4 Central& SoutHAmerica Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Human Papillomavirus (HPV) Testing Introduction
13.1.4 Roche Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Agilent Technologies
13.2.1 Agilent Technologies Company Details
13.2.2 Agilent Technologies Business Overview
13.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Introduction
13.2.4 Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
13.2.5 Agilent Technologies Recent Development
13.3 Becton, DickinsonandCompany
13.3.1 Becton, DickinsonandCompany Company Details
13.3.2 Becton, DickinsonandCompany Business Overview
13.3.3 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Introduction
13.3.4 Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
13.3.5 Becton, DickinsonandCompany Recent Development
13.4 QiagenN.V.
13.4.1 QiagenN.V. Company Details
13.4.2 QiagenN.V. Business Overview
13.4.3 QiagenN.V. Human Papillomavirus (HPV) Testing Introduction
13.4.4 QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
13.4.5 QiagenN.V. Recent Development
13.5 Thermo FisherScientificInc.
13.5.1 Thermo FisherScientificInc. Company Details
13.5.2 Thermo FisherScientificInc. Business Overview
13.5.3 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Introduction
13.5.4 Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
13.5.5 Thermo FisherScientificInc. Recent Development
13.6 Abbott Laboratories
13.6.1 Abbott Laboratories Company Details
13.6.2 Abbott Laboratories Business Overview
13.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Introduction
13.6.4 Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
13.6.5 Abbott Laboratories Recent Development
13.7 HologicInc.
13.7.1 HologicInc. Company Details
13.7.2 HologicInc. Business Overview
13.7.3 HologicInc. Human Papillomavirus (HPV) Testing Introduction
13.7.4 HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
13.7.5 HologicInc. Recent Development
13.8 CepheidInc.
13.8.1 CepheidInc. Company Details
13.8.2 CepheidInc. Business Overview
13.8.3 CepheidInc. Human Papillomavirus (HPV) Testing Introduction
13.8.4 CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
13.8.5 CepheidInc. Recent Development
13.9 SeegeneInc.
13.9.1 SeegeneInc. Company Details
13.9.2 SeegeneInc. Business Overview
13.9.3 SeegeneInc. Human Papillomavirus (HPV) Testing Introduction
13.9.4 SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
13.9.5 SeegeneInc. Recent Development
13.10 TakaraBio Inc.
13.10.1 TakaraBio Inc. Company Details
13.10.2 TakaraBio Inc. Business Overview
13.10.3 TakaraBio Inc. Human Papillomavirus (HPV) Testing Introduction
13.10.4 TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
13.10.5 TakaraBio Inc. Recent Development
13.11 DaAnGeneof SunYat-SenUniversity
10.11.1 DaAnGeneof SunYat-SenUniversity Company Details
10.11.2 DaAnGeneof SunYat-SenUniversity Business Overview
10.11.3 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Introduction
10.11.4 DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.11.5 DaAnGeneof SunYat-SenUniversity Recent Development
13.12 PromegaCorporation
10.12.1 PromegaCorporation Company Details
10.12.2 PromegaCorporation Business Overview
10.12.3 PromegaCorporation Human Papillomavirus (HPV) Testing Introduction
10.12.4 PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.12.5 PromegaCorporation Recent Development
13.13 GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
10.13.1 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Details
10.13.2 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview
10.13.3 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Introduction
10.13.4 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.13.5 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Development
13.14 Enzo Biochem Inc.
10.14.1 Enzo Biochem Inc. Company Details
10.14.2 Enzo Biochem Inc. Business Overview
10.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Introduction
10.14.4 Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.14.5 Enzo Biochem Inc. Recent Development
13.15 NorgenBiotek
10.15.1 NorgenBiotek Company Details
10.15.2 NorgenBiotek Business Overview
10.15.3 NorgenBiotek Human Papillomavirus (HPV) Testing Introduction
10.15.4 NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.15.5 NorgenBiotek Recent Development
13.16 DiagCorBioscienceIncLtd
10.16.1 DiagCorBioscienceIncLtd Company Details
10.16.2 DiagCorBioscienceIncLtd Business Overview
10.16.3 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Introduction
10.16.4 DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.16.5 DiagCorBioscienceIncLtd Recent Development
13.17 Hybribio Limited
10.17.1 Hybribio Limited Company Details
10.17.2 Hybribio Limited Business Overview
10.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Introduction
10.17.4 Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.17.5 Hybribio Limited Recent Development
13.18 ZytovisionGmbH
10.18.1 ZytovisionGmbH Company Details
10.18.2 ZytovisionGmbH Business Overview
10.18.3 ZytovisionGmbH Human Papillomavirus (HPV) Testing Introduction
10.18.4 ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.18.5 ZytovisionGmbH Recent Development
13.19 ArborVitaCorporation
10.19.1 ArborVitaCorporation Company Details
10.19.2 ArborVitaCorporation Business Overview
10.19.3 ArborVitaCorporation Human Papillomavirus (HPV) Testing Introduction
10.19.4 ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.19.5 ArborVitaCorporation Recent Development
13.20 Medical& BiologicalLaboratoriesCo., Ltd
10.20.1 Medical& BiologicalLaboratoriesCo., Ltd Company Details
10.20.2 Medical& BiologicalLaboratoriesCo., Ltd Business Overview
10.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Introduction
10.20.4 Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Development
13.21 Fujirebio Diagnostics
10.21.1 Fujirebio Diagnostics Company Details
10.21.2 Fujirebio Diagnostics Business Overview
10.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Introduction
10.21.4 Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020)
10.21.5 Fujirebio Diagnostics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Human Papillomavirus (HPV) Testing Key Market Segments

Table 2. Key Players Covered: Ranking by Human Papillomavirus (HPV) Testing Revenue

Table 3. Ranking of Global Top Human Papillomavirus (HPV) Testing Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Pap Smear Test

Table 6. Key Players of HPV DNA Test

Table 7. Global Human Papillomavirus (HPV) Testing Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 8. Global Human Papillomavirus (HPV) Testing Market Size by Regions (US$ Million): 2020 VS 2026

Table 9. Global Human Papillomavirus (HPV) Testing Market Size by Regions (2015-2020) (US$ Million)

Table 10. Global Human Papillomavirus (HPV) Testing Market Share by Regions (2015-2020)

Table 11. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 12. Global Human Papillomavirus (HPV) Testing Market Share by Regions (2021-2026)

Table 13. Market Top Trends

Table 14. Key Drivers: Impact Analysis

Table 15. Key Challenges

Table 16. Human Papillomavirus (HPV) Testing Market Growth Strategy

Table 17. Main Points Interviewed from Key Human Papillomavirus (HPV) Testing Players

Table 18. Global Human Papillomavirus (HPV) Testing Revenue by Players (2015-2020) (Million US$)

Table 19. Global Human Papillomavirus (HPV) Testing Market Share by Players (2015-2020)

Table 20. Global Top Human Papillomavirus (HPV) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2019)

Table 21. Global Human Papillomavirus (HPV) Testing by Players Market Concentration Ratio (CR5 and HHI)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Human Papillomavirus (HPV) Testing Product Solution and Service

Table 24. Date of Enter into Human Papillomavirus (HPV) Testing Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020) (Million US$)

Table 27. Global Human Papillomavirus (HPV) Testing Market Size Share by Type (2015-2020)

Table 28. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type (2021-2026)

Table 29. Global Human Papillomavirus (HPV) Testing Market Size Share by Application (2015-2020)

Table 30. Global Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020) (Million US$)

Table 31. Global Human Papillomavirus (HPV) Testing Market Size Share by Application (2021-2026)

Table 32. NortHAmerica Key Players Human Papillomavirus (HPV) Testing Revenue (2019-2020) (Million US$)

Table 33. NortHAmerica Key Players Human Papillomavirus (HPV) Testing Market Share (2019-2020)

Table 34. NortHAmerica Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020) (Million US$)

Table 35. NortHAmerica Human Papillomavirus (HPV) Testing Market Share by Type (2015-2020)

Table 36. NortHAmerica Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020) (Million US$)

Table 37. NortHAmerica Human Papillomavirus (HPV) Testing Market Share by Application (2015-2020)

Table 38. Europe Key Players Human Papillomavirus (HPV) Testing Revenue (2019-2020) (Million US$)

Table 39. Europe Key Players Human Papillomavirus (HPV) Testing Market Share (2019-2020)

Table 40. Europe Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020) (Million US$)

Table 41. Europe Human Papillomavirus (HPV) Testing Market Share by Type (2015-2020)

Table 42. Europe Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020) (Million US$)

Table 43. Europe Human Papillomavirus (HPV) Testing Market Share by Application (2015-2020)

Table 44. China Key Players Human Papillomavirus (HPV) Testing Revenue (2019-2020) (Million US$)

Table 45. China Key Players Human Papillomavirus (HPV) Testing Market Share (2019-2020)

Table 46. China Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020) (Million US$)

Table 47. China Human Papillomavirus (HPV) Testing Market Share by Type (2015-2020)

Table 48. China Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020) (Million US$)

Table 49. China Human Papillomavirus (HPV) Testing Market Share by Application (2015-2020)

Table 50. Japan Key Players Human Papillomavirus (HPV) Testing Revenue (2019-2020) (Million US$)

Table 51. Japan Key Players Human Papillomavirus (HPV) Testing Market Share (2019-2020)

Table 52. Japan Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020) (Million US$)

Table 53. Japan Human Papillomavirus (HPV) Testing Market Share by Type (2015-2020)

Table 54. Japan Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020) (Million US$)

Table 55. Japan Human Papillomavirus (HPV) Testing Market Share by Application (2015-2020)

Table 56. Southeast Asia Key Players Human Papillomavirus (HPV) Testing Revenue (2019-2020) (Million US$)

Table 57. Southeast Asia Key Players Human Papillomavirus (HPV) Testing Market Share (2019-2020)

Table 58. Southeast Asia Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020) (Million US$)

Table 59. Southeast Asia Human Papillomavirus (HPV) Testing Market Share by Type (2015-2020)

Table 60. Southeast Asia Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020) (Million US$)

Table 61. Southeast Asia Human Papillomavirus (HPV) Testing Market Share by Application (2015-2020)

Table 62. India Key Players Human Papillomavirus (HPV) Testing Revenue (2019-2020) (Million US$)

Table 63. India Key Players Human Papillomavirus (HPV) Testing Market Share (2019-2020)

Table 64. India Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020) (Million US$)

Table 65. India Human Papillomavirus (HPV) Testing Market Share by Type (2015-2020)

Table 66. India Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020) (Million US$)

Table 67. India Human Papillomavirus (HPV) Testing Market Share by Application (2015-2020)

Table 68. Central& SoutHAmerica Key Players Human Papillomavirus (HPV) Testing Revenue (2019-2020) (Million US$)

Table 69. Central& SoutHAmerica Key Players Human Papillomavirus (HPV) Testing Market Share (2019-2020)

Table 70. Central& SoutHAmerica Human Papillomavirus (HPV) Testing Market Size by Type (2015-2020) (Million US$)

Table 71. Central& SoutHAmerica Human Papillomavirus (HPV) Testing Market Share by Type (2015-2020)

Table 72. Central& SoutHAmerica Human Papillomavirus (HPV) Testing Market Size by Application (2015-2020) (Million US$)

Table 73. Central& SoutHAmerica Human Papillomavirus (HPV) Testing Market Share by Application (2015-2020)

Table 74. Roche Company Details

Table 75. Roche Business Overview

Table 76. Roche Product

Table 77. Roche Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 78. Roche Recent Development

Table 79. Agilent Technologies Company Details

Table 80. Agilent Technologies Business Overview

Table 81. Agilent Technologies Product

Table 82. Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 83. Agilent Technologies Recent Development

Table 84. Becton, DickinsonandCompany Company Details

Table 85. Becton, DickinsonandCompany Business Overview

Table 86. Becton, DickinsonandCompany Product

Table 87. Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 88. Becton, DickinsonandCompany Recent Development

Table 89. QiagenN.V. Company Details

Table 90. QiagenN.V. Business Overview

Table 91. QiagenN.V. Product

Table 92. QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 93. QiagenN.V. Recent Development

Table 94. Thermo FisherScientificInc. Company Details

Table 95. Thermo FisherScientificInc. Business Overview

Table 96. Thermo FisherScientificInc. Product

Table 97. Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 98. Thermo FisherScientificInc. Recent Development

Table 99. Abbott Laboratories Company Details

Table 100. Abbott Laboratories Business Overview

Table 101. Abbott Laboratories Product

Table 102. Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 103. Abbott Laboratories Recent Development

Table 104. HologicInc. Company Details

Table 105. HologicInc. Business Overview

Table 106. HologicInc. Product

Table 107. HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 108. HologicInc. Recent Development

Table 109. CepheidInc. Business Overview

Table 110. CepheidInc. Product

Table 111. CepheidInc. Company Details

Table 112. CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 113. CepheidInc. Recent Development

Table 114. SeegeneInc. Company Details

Table 115. SeegeneInc. Business Overview

Table 116. SeegeneInc. Product

Table 117. SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 118. SeegeneInc. Recent Development

Table 119. TakaraBio Inc. Company Details

Table 120. TakaraBio Inc. Business Overview

Table 121. TakaraBio Inc. Product

Table 122. TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 123. TakaraBio Inc. Recent Development

Table 124. DaAnGeneof SunYat-SenUniversity Company Details

Table 125. DaAnGeneof SunYat-SenUniversity Business Overview

Table 126. DaAnGeneof SunYat-SenUniversity Product

Table 127. DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 128. DaAnGeneof SunYat-SenUniversity Recent Development

Table 129. PromegaCorporation Company Details

Table 130. PromegaCorporation Business Overview

Table 131. PromegaCorporation Product

Table 132. PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 133. PromegaCorporation Recent Development

Table 134. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Details

Table 135. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview

Table 136. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Product

Table 137. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 138. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Development

Table 139. Enzo Biochem Inc. Company Details

Table 140. Enzo Biochem Inc. Business Overview

Table 141. Enzo Biochem Inc. Product

Table 142. Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 143. Enzo Biochem Inc. Recent Development

Table 144. NorgenBiotek Company Details

Table 145. NorgenBiotek Business Overview

Table 146. NorgenBiotek Product

Table 147. NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 148. NorgenBiotek Recent Development

Table 149. DiagCorBioscienceIncLtd Company Details

Table 150. DiagCorBioscienceIncLtd Business Overview

Table 151. DiagCorBioscienceIncLtd Product

Table 152. DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 153. DiagCorBioscienceIncLtd Recent Development

Table 154. Hybribio Limited Company Details

Table 155. Hybribio Limited Business Overview

Table 156. Hybribio Limited Product

Table 157. Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 158. Hybribio Limited Recent Development

Table 159. ZytovisionGmbH Company Details

Table 160. ZytovisionGmbH Business Overview

Table 161. ZytovisionGmbH Product

Table 162. ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 163. ZytovisionGmbH Recent Development

Table 164. ArborVitaCorporation Company Details

Table 165. ArborVitaCorporation Business Overview

Table 166. ArborVitaCorporation Product

Table 167. ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 168. ArborVitaCorporation Recent Development

Table 169. Medical& BiologicalLaboratoriesCo., Ltd Company Details

Table 170. Medical& BiologicalLaboratoriesCo., Ltd Business Overview

Table 171. Medical& BiologicalLaboratoriesCo., Ltd Product

Table 172. Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 173. Medical& BiologicalLaboratoriesCo., Ltd Recent Development

Table 174. Fujirebio Diagnostics Company Details

Table 175. Fujirebio Diagnostics Business Overview

Table 176. Fujirebio Diagnostics Product

Table 177. Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2015-2020) (Million US$)

Table 178. Fujirebio Diagnostics Recent Development

Table 179. Research Programs/Design for This Report

Table 180. Key Data Information from Secondary Sources

Table 181. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Human Papillomavirus (HPV) Testing Market Share by Type: 2020 VS 2026

Figure 2. Pap Smear Test Features

Figure 3. HPV DNA Test Features

Figure 4. Global Human Papillomavirus (HPV) Testing Market Share by Application: 2020 VS 2026

Figure 5. Diagnostic Centers Case Studies

Figure 6. Hospitals Case Studies

Figure 7. Clinic Case Studies

Figure 8. Human Papillomavirus (HPV) Testing Report Years Considered

Figure 9. Global Human Papillomavirus (HPV) Testing Market Size YoY Growth 2015-2026 (US$ Million)

Figure 10. Global Human Papillomavirus (HPV) Testing Market Share by Regions: 2020 VS 2026

Figure 11. Global Human Papillomavirus (HPV) Testing Market Share by Regions (2021-2026)

Figure 12. Porter's Five Forces Analysis

Figure 13. Global Human Papillomavirus (HPV) Testing Market Share by Players in 2019

Figure 14. Global Top Human Papillomavirus (HPV) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2019

Figure 15. The Top 10 and 5 Players Market Share by Human Papillomavirus (HPV) Testing Revenue in 2019

Figure 16. NortHAmerica Human Papillomavirus (HPV) Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 17. Europe Human Papillomavirus (HPV) Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. China Human Papillomavirus (HPV) Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. Japan Human Papillomavirus (HPV) Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Southeast Asia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. India Human Papillomavirus (HPV) Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Central& SoutHAmerica Human Papillomavirus (HPV) Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Bottom-up and Top-down Approaches for This Report

Figure 24. Data Triangulation

Figure 25. Key Executives Interviewed

Roche

Agilent Technologies

Becton, DickinsonandCompany

QiagenN.V.

Thermo FisherScientificInc.

Abbott Laboratories

HologicInc.

CepheidInc.

SeegeneInc.

TakaraBio Inc.

DaAnGeneof SunYat-SenUniversity

PromegaCorporation

GreinerBio-OneInternationalGmbH(GreinerHoldingAG)

Enzo Biochem Inc.

NorgenBiotek

DiagCorBioscienceIncLtd

Hybribio Limited

ZytovisionGmbH

ArborVitaCorporation

Medical& BiologicalLaboratoriesCo., Ltd

Fujirebio Diagnostics

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3042

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase